A global life science company needed needed a fresh look at the competitiveness of its US portfolio with respect to current products and the five-year pipeline. Lacking the internal resources to complete the project—and hoping to avoid the heavy footprint of a traditional consulting firm—the CEO of the company’s US operations turned to Business Talent Group.
Our three-person team of experienced consultants and practitioners delivered a quick, actionable assessment of the medium-term competitiveness of the company’s portfolio. They then developed a series of strategic options the company could use over the next five years to strengthen its relative position. The team’s operating experience expedited the deliverable and added valuable market context—at a total cost of less than one-third of what a big consulting firm would have charged.
